These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 12160856)

  • 1. Resistance of human fungal pathogens to antifungal drugs.
    Sanglard D
    Curr Opin Microbiol; 2002 Aug; 5(4):379-85. PubMed ID: 12160856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal resistance: why are we losing this battle?
    Paiva Macedo J; Dias VC
    Future Microbiol; 2024; 19(11):1027-1040. PubMed ID: 38904325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beauvericin Potentiates Azole Activity via Inhibition of Multidrug Efflux, Blocks Candida albicans Morphogenesis, and Is Effluxed via Yor1 and Circuitry Controlled by Zcf29.
    Shekhar-Guturja T; Tebung WA; Mount H; Liu N; Köhler JR; Whiteway M; Cowen LE
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7468-7480. PubMed ID: 27736764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genesis of Azole Antifungal Resistance from Agriculture to Clinical Settings.
    Azevedo MM; Faria-Ramos I; Cruz LC; Pina-Vaz C; Rodrigues AG
    J Agric Food Chem; 2015 Sep; 63(34):7463-8. PubMed ID: 26289797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a serious risk of resistance development to azoles among fungi due to the widespread use and long-term application of azole antifungals in medicine?
    Hof H
    Drug Resist Updat; 2008; 11(1-2):25-31. PubMed ID: 18325827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factor CCG-8 plays a pivotal role in azole adaptive responses of Neurospora crassa by regulating intracellular azole accumulation.
    Xue W; Yin Y; Ismail F; Hu C; Zhou M; Cao X; Li S; Sun X
    Curr Genet; 2019 Jun; 65(3):735-745. PubMed ID: 30603874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordinated Regulation of Membrane Homeostasis and Drug Accumulation by Novel Kinase STK-17 in Response to Antifungal Azole Treatment.
    Hu C; Zhou M; Cao X; Xue W; Zhang Z; Li S; Sun X
    Microbiol Spectr; 2022 Feb; 10(1):e0012722. PubMed ID: 35196787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linkage between genes involved in azole resistance and ergosterol biosynthesis.
    Moye-Rowley WS
    PLoS Pathog; 2020 Sep; 16(9):e1008819. PubMed ID: 32881974
    [No Abstract]   [Full Text] [Related]  

  • 10. Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs.
    Mount HO; Revie NM; Todd RT; Anstett K; Collins C; Costanzo M; Boone C; Robbins N; Selmecki A; Cowen LE
    PLoS Genet; 2018 Apr; 14(4):e1007319. PubMed ID: 29702647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Genomics for the Elucidation of Multidrug Resistance in Candida lusitaniae.
    Kannan A; Asner SA; Trachsel E; Kelly S; Parker J; Sanglard D
    mBio; 2019 Dec; 10(6):. PubMed ID: 31874914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medically important fungi respond to azole drugs: an update.
    Zavrel M; White TC
    Future Microbiol; 2015; 10(8):1355-73. PubMed ID: 26234644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of resistance to azole antifungals.
    Lupetti A; Danesi R; Campa M; Del Tacca M; Kelly S
    Trends Mol Med; 2002 Feb; 8(2):76-81. PubMed ID: 11815273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nationwide passive surveillance on fungal infections shows a low burden of azole resistance in molds and yeasts in Tyrol, Austria.
    Lass-Flörl C; Mayr A; Aigner M; Lackner M; Orth-Höller D
    Infection; 2018 Oct; 46(5):701-704. PubMed ID: 29971692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azole Resistance of Environmental and Clinical Aspergillus fumigatus Isolates from Switzerland.
    Riat A; Plojoux J; Gindro K; Schrenzel J; Sanglard D
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437612
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
    Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
    Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanisms of resistance to antifungal agents].
    Makimura K
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():466-70. PubMed ID: 17455664
    [No Abstract]   [Full Text] [Related]  

  • 18. Targeting efflux pumps to overcome antifungal drug resistance.
    Holmes AR; Cardno TS; Strouse JJ; Ivnitski-Steele I; Keniya MV; Lackovic K; Monk BC; Sklar LA; Cannon RD
    Future Med Chem; 2016 Aug; 8(12):1485-501. PubMed ID: 27463566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced susceptibility of Candida albicans clinical isolates to azoles and detection of mutations in the ERG11 gene.
    Zhang L; Yang HF; Liu YY; Xu XH; Ye Y; Li JB
    Diagn Microbiol Infect Dis; 2013 Dec; 77(4):327-9. PubMed ID: 24070847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidating drug resistance in human fungal pathogens.
    Xie JL; Polvi EJ; Shekhar-Guturja T; Cowen LE
    Future Microbiol; 2014; 9(4):523-42. PubMed ID: 24810351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.